Pharmaceutical Industry

Page 92 of 100

Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
Finance

Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival

By
July 7, 2015
186815051
Tech

Despite regulatory troubles, DNA testing firm 23andMe raises more money

By
July 2, 2015
These are the Fortune 500’s fastest-growing pharma companies
Features

These are the Fortune 500’s fastest-growing pharma companies

By
June 20, 2015
The 10 Biggest Health Care Companies in the Fortune 500
Features

The 10 Biggest Health Care Companies in the Fortune 500

By
June 20, 2015
These Fortune 500 companies leapfrogged the rest
Finance

These Fortune 500 companies leapfrogged the rest

By
June 19, 2015
Flibanserin
Features

A female Viagra is one step closer to reality

By
June 4, 2015
Food and Farm Livestock Antibiotics
Retail

Antibiotics in meat: A public health controversy that isn’t going away

By
June 3, 2015
Bristol-Myers Squibb R&D headquarters
Tech

New cancer drug combo shrinks tumors in 60% of patients – study

By TIME and Fortune Editors
June 1, 2015
19 kids and cancelled: TV shows that got pulled due to controversy
Arts & Entertainment

19 kids and cancelled: TV shows that got pulled due to controversy

By
May 28, 2015
Can Gilead keep growing without a big deal?
Finance

Can Gilead keep growing without a big deal?

By
May 23, 2015
JPMorgan Chase & Co. CEO Jamie Dimon Speaks At An Institute Of International Finance Panel
Features

ECB peps markets and JPMorgan shareholders vote on Dimon’s pay–5 things to know today

By
May 19, 2015
157934085
Features

The pharma M&A party is still in full swing, as Endo snaps up Par

By
May 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
Tech

GlaxoSmithKline plans to work with U.S. scientists to develop a cure for AIDS

By
May 11, 2015
Biopharma deals are booming this year with no end in sight
Finance

Biopharma deals are booming this year with no end in sight

By
May 8, 2015
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
Features

Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher

By
May 8, 2015

Most Popular